Exicure

Exicure is developing a new class of immunomodulatory and gene silencing drugs against validated targets.

HQ location

Chicago, United States

Website

Launch date

2009

Employees

Market cap

Enterprise value

$28m

Share price

$5.61 XCUR

Jobs

View job openings

Recent deals

Cyworld

https://twitter.com/exicure http://www.facebook.com/pages/AuraSense-Therapeutics/308079542559695 https://www.linkedin.com/company/exicure

Authorizing premium user...